Proyecto de Investigación

RECOMBINANT SOLUBLE ISOFORM OF THE HUMAN IFNSS RECEPTOR (ISOL) AS A POTENTIAL THERAPEUTIC MOLECULE FOR MULTIPLE SCLEROSIS

Financed by: European Commission

Programme: INEXT- INFRASTRUCTURE FOR NMR, EM AND X-RAYS FOR TRANSLATIONAL RESEARCH 2018

Grant Agreement ID: CE-INFRA-INEXT-2018-01 

 

Contact: Laricchia-Robbio, Leopoldo

Implementation Centre: Hospital Regional Universitario de Málaga

Research group of IBIMA involved: Neuroimmunology and Neuroinflammation